Related Experiment Videos
Changing trends in hepatic resection for malignant liver tumours
1Department of Surgery, Royal Postgraduate Medical School, Hammersmith Hospital, London, UK.
International Surgery
|October 1, 1993
Summary
Liver resection for malignant tumors is a safe procedure with low operative mortality (1.5%). This surgical approach is now routinely used for both curative and palliative care in advanced liver cancer cases.
Area of Science:
- Hepatobiliary Surgery
- Surgical Oncology
- Gastroenterology
Background:
- Liver resections for malignant tumors were historically considered major operations with significant risks.
- Patient selection criteria for liver resection have evolved over time.
- The Hammersmith Hospital has a history of performing complex liver surgeries.
Purpose of the Study:
- To review the outcomes of liver resections performed for malignant tumors.
- To assess the safety and efficacy of liver resection in a specific patient cohort.
- To evaluate the evolving indications for liver resection, including palliative care.
Main Methods:
- Retrospective review of 57 patients who underwent 65 liver resections for malignant tumors.
- Data collected from August 1989 to November 1992 at Hammersmith Hospital.
- Analysis of various resection types, operative mortality, hospital stay, and recurrence rates.
Main Results:
- Operative mortality was low at 1.5% (1 patient).
- Mean postoperative hospital stay was 19.7 days.
- Repeated liver resections for tumor recurrence showed satisfactory early results.
- Resectability criteria have been relaxed, extending indications to advanced lesions for palliation.
Conclusions:
- Liver resection has become a routine and safe surgical procedure.
- Improvements in surgical outcomes have broadened the application of liver resection.
- The procedure is now utilized for both curative intent in early tumors and palliative care in advanced lesions.